Clinical Trial Update: The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update assessing the effects of RVX000222 on glucose metabolism in individuals with prediabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Prediabetes

Drugs mentioned

• RVX000222 (apabetalone)

Snippet

Sponsor: Resverlogix Corp | Conditions: Diabetes | Phase 2 | Status: COMPLETED